Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma
Top Cited Papers
Open Access
- 1 February 2010
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 138 (2), 493-502
- https://doi.org/10.1053/j.gastro.2009.10.031
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose PeginterferonNew England Journal of Medicine, 2008
- AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver diseaseBMC Cancer, 2008
- Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the WorldJournal of Clinical Oncology, 2006
- Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C TrialJournal of Hepatology, 2005
- Randomized controlled trial of screening for hepatocellular carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2004
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosisJournal of Hepatology, 1994
- Production of abnormal prothrombin (des-γ-carboxy prothrombin) by hepatocellular carcinomaJournal of Hepatology, 1987
- Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular CarcinomaNew England Journal of Medicine, 1984